Abstract:Background:With the advancement of early detection and treatment, the incidence of colon cancer (CC) has declined steadily worldwide; however, the mortality remains unacceptably high. Tripartite motif 52 (TRIM52) is a member of the family of highly conserved RBCC (a RING-finger, two B-boxes, and a predicted alpha-helical Coiled-Coil domain were linked to the N-terminal region in sequence) proteins with more than 70 isoforms, which plays an important role in tumorigenesis through different signaling pathways. How it regulates the development of CC remains unknown.Methods:Western blot was used to reveal that TRIM52 protein expression is up-regulated in CC cells. The Analysis of The Cancer Genome Atlas (TCGA) database was used to find the different expressions of TRIM52 between colon cancer tissues and normal colonic epithelial tissues. Cell proliferation assays, migration and invasion assays, and apoptosis were used to verify the changes in cell function after knockdown or overexpression of TRIM52 in CC cells. After that, the key proteins of the nuclear factor (NF)-κB signaling pathway were validated by western blot to explore the role of TRIM52 in the NF-κB signaling pathway. Finally, in order to explore the potential sites of TRIM52, LPS and PDTC were employed to activate and block the NF-κB signaling pathway, and the key proteins of the NF-κB signaling pathway were validated by western blot.Results:TGCA database revealed that TRIM52 expression was elevated in CC tissues and correlated with prognosis. It was verified that TRIM52 promoted the proliferation, migration, and invasion of CC cells, and inhibited cell apoptosis. Most of the tripartite motif proteins (TRIMs) have ubiquitin ligase activity related to their highly conserved RING structure. Detection of the key proteins of the NF-κB signaling pathway in CC cells revealed that TRIM52 activated the NF-κB signaling pathway.Conclusions:We confirmed that TRIM52 promotes proliferation, migration, and invasion while inhibiting apoptosis of CC cells. The regulatory effect of TRIM52 on CC cells is related to the activation of the NF-κB signaling pathway. As TRIM52 acted as an upstream stimulator, stimulating the transfer of P65 into the nucleus to activate the NF-κB signaling pathway, it may provide a potential target for prognosis prediction and treatment of CC.

TRIM67 Suppresses TNFalpha-Triggered NF-kB Activation by Competitively Binding Beta-TrCP to IkBa.

Trim30 Alpha Negatively Regulates Tlr-Mediated Nf-Kappa B Activation By Targeting Tab2 And Tab3 For Degradation

TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation

TRIM 30 a negatively regulates TLR-mediated NF-j B activation by targeting TAB 2 and TAB 3 for degradation

TRIM26 Positively Regulates the Inflammatory Immune Response Through K11-linked Ubiquitination of TAB1

TRIM38 Inhibits TNFα- and IL-1β–triggered NF-κB Activation by Mediating Lysosome-Dependent Degradation of TAB2/3

Tripartite Motif 8 (TRIM8) Modulates TNFα- and IL-1β–triggered NF-κB Activation by Targeting TAK1 for K63-linked Polyubiquitination

Tripartite Motif-Containing (TRIM) 21 Negatively Regulates Intestinal Mucosal Inflammation Through Inhibiting TH1/TH17 Cell Differentiation in Patients with Inflammatory Bowel Diseases.

E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer

Negative Regulation of NF-κB Activity by Brain-Specific TRIpartite Motif Protein 9

TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin

Trim38 Negatively Regulates Tlr3/4-Mediated Innate Immune and Inflammatory Responses by Two Sequential and Distinct Mechanisms

TRIM14 Promotes Noncanonical NF‐κB Activation by Modulating p100/p52 Stability via Selective Autophagy

TRIM8 Negatively Regulates TLR3/4-Mediated Innate Immune Response by Blocking TRIF–TBK1 Interaction

TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway

The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3

TRIM38 Negatively Regulates TLR3-mediated IFN-β Signaling by Targeting TRIF for Degradation.

Tripartite Motif 52 (TRIM52) Promotes Proliferation, Migration, and Regulation of Colon Cancer Cells Associated with the NF-κB Signaling Pathway.

E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages.

TRIM14 Promotes Endothelial Activation Via Activating NF-κB Signaling Pathway

Identification of Tripartite Motif-Containing 22 (TRIM22) As a Novel NF-κB Activator.